Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BY 4.0Food Science & Nutrition

XuanBi Mitigates Rheumatoid Arthritis via Regulation of ECM‐Receptor Interactions and IL‐17 Signaling: Insights From Integrated Proteomic and Pharmacological Analyses

  • Hao Zhu1
  • Zhenfeng Pan2
  • Ying Lu3
  • Ping Xia1
  • Weiming He4
  • Jingqi Zeng5
  • Fan Wang5
  • Xiao Liu6
  • Minggang Wei1
6 affiliations
  1. 1Department of Traditional Chinese Medicine The First Affiliated Hospital of Soochow University, Soochow University Suzhou China
  2. 2Department of Pharmacy The First Affiliated Hospital of Soochow University, Soochow University Suzhou China
  3. 3Department of Integrated Traditional Chinese and Western Medicine Dushu Lake Hospital, Soochow University Suzhou China
  4. 4Department of Nephrology Jiangsu Province Hospital of Chinese Medicine Nanjing China
  5. 5Department of Orthopedics The Second Affiliated Hospital of Hunan University of Chinese Medicine (Hunan Traditional Chinese Medical Hospital) Changsha China
  6. 6Department of Burn and Plastic Surgery The First Affiliated Hospital of Soochow University, Soochow University Suzhou China
Read full textPDFDOICite

Abstract

Plant‐derived polyphenols possess broad anti‐inflammatory activities and may benefit chronic inflammatory diseases. XuanBi is a traditional Chinese medicine formula containing orally absorbable polyphenolic constituents and is used to treat rheumatoid arthritis (RA). This study investigated its absorbable components and potential mechanisms associated with synovial inflammatory hyperplasia. XuanBi was evaluated in collagen‐induced arthritis (CIA) rats and rheumatoid arthritis synovial fibroblasts (RASFs). Constituents in the decoction and rat serum were characterized by high‐performance liquid chromatography coupled with quadrupole‐Orbitrap mass spectrometry (HPLC‐Q‐Orbitrap‐MS). Predicted targets were intersected with synovial differentially expressed proteins (DEPs), followed by network pharmacology, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, and experimental validation. Twenty‐six absorbable constituents were identified, including catechin, quercetin, baicalein, and wogonin, together with 14 candidate proteins associated with RA synovial pathology. Enrichment analysis implicated extracellular matrix (ECM)–receptor interaction, focal adhesion, and interleukin‐17 (IL‐17) signaling. Medium‐ and high‐dose XuanBi reduced joint swelling, synovial hyperplasia, and inflammatory infiltration in CIA rats. In RASFs, XuanBi inhibited proliferation, migration, and invasion. It also downregulated fibronectin 1 (FN1) and caveolin 1 (CAV1), reduced phosphorylation of SRC, focal adhesion kinase (FAK), and FYN, decreased integrin alpha 2b (ITGA2B)+/integrin beta 1 (ITGB1)+ cells, and reduced interleukin‐1 beta (IL‐1β), interleukin‐6 (IL‐6), tumor necrosis factor alpha (TNF‐α), matrix metallopeptidase 3 (MMP3), and matrix metallopeptidase 9 (MMP9). Overall, XuanBi exerted anti‐inflammatory and anti‐synovial‐hyperplasia effects in experimental RA, accompanied by changes in proteins associated with these pathways, supporting the potential involvement of these pathways and warranting further mechanistic and clinical investigation.

Related

  1. Huoxi Qufeng medicinal liquor alleviates rheumatoid arthritis lesions: Bioinformatic prediction of EGFR-related JAK-STAT/PI3K-Akt pathways and in vivo pharmacological validation
    XiaoJie Wang, LongLong Li, Jing Zhong +5
    Results in ChemistryPeer-reviewedCC BYFull textGeneral medicineDOAJ
  2. Pharmacological regulation of chondrocyte ferroptosis by plant-derived metabolites in osteoarthritis: from molecular mechanisms to targeted nanodelivery
    Tianci Guo, Qi Liu, Jida Wang +4
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCCrossref
  3. Tryptophan metabolism circadian regulation: clinical and pharmacological implications
    Consuelo Fabi, Sarah Balucchi, Marina Maria Bellet
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPhysiologyCrossrefPMC
  4. CPR-Centered Redox Interactions Between Cytochrome P450 Oxidoreductase and Cytochrome c Oxidase: Potential Pharmacological Implications
    Vladimir S. Ponamarev
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMC
  5. Microenvironment-Triggered Sequentially Targeted Micelles for Dual Regulation of Macrophages and Fibroblast-Like Synoviocytes via ROS-Responsive Rg1 Release and HAP-1-Mediated Celastrol Delivery in Rheumatoid Arthritis Therapy.
    Yani Zhang, Ruibo Guo, Ying Zheng +7
    International journal of nanomedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{zhu2026xuanbi,
  title = {{XuanBi Mitigates Rheumatoid Arthritis via Regulation of ECM‐Receptor Interactions and IL‐17 Signaling: Insights From Integrated Proteomic and Pharmacological Analyses}},
  author = {Hao Zhu and Zhenfeng Pan and Ying Lu and Ping Xia and Weiming He and Jingqi Zeng and Fan Wang and Xiao Liu and Minggang Wei},
  journal = {Food Science \& Nutrition},
  year = {2026},
  month = oct,
  doi = {10.1002/fsn3.72498},
  url = {https://doi.org/10.1002/fsn3.72498},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - XuanBi Mitigates Rheumatoid Arthritis via Regulation of ECM‐Receptor Interactions and IL‐17 Signaling: Insights From Integrated Proteomic and Pharmacological Analyses
AU  - Hao Zhu
AU  - Zhenfeng Pan
AU  - Ying Lu
AU  - Ping Xia
AU  - Weiming He
AU  - Jingqi Zeng
AU  - Fan Wang
AU  - Xiao Liu
AU  - Minggang Wei
PY  - 2026
DA  - 2026/10/25
JO  - Food Science & Nutrition
DO  - 10.1002/fsn3.72498
UR  - https://doi.org/10.1002/fsn3.72498
AB  - Plant‐derived polyphenols possess broad anti‐inflammatory activities and may benefit chronic inflammatory diseases. XuanBi is a traditional Chinese medicine formula containing orally absorbable polyphenolic constituents and is used to treat rheumatoid arthritis (RA). This study investigated its absorbable components and potential mechanisms associated with synovial inflammatory hyperplasia. XuanBi was evaluated in collagen‐induced arthritis (CIA) rats and rheumatoid arthritis synovial fibroblasts (RASFs). Constituents in the decoction and rat serum were characterized by high‐performance liquid chromatography coupled with quadrupole‐Orbitrap mass spectrometry (HPLC‐Q‐Orbitrap‐MS). Predicted targets were intersected with synovial differentially expressed proteins (DEPs), followed by network pharmacology, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, and experimental validation. Twenty‐six absorbable constituents were identified, including catechin, quercetin, baicalein, and wogonin, together with 14 candidate proteins associated with RA synovial pathology. Enrichment analysis implicated extracellular matrix (ECM)–receptor interaction, focal adhesion, and interleukin‐17 (IL‐17) signaling. Medium‐ and high‐dose XuanBi reduced joint swelling, synovial hyperplasia, and inflammatory infiltration in CIA rats. In RASFs, XuanBi inhibited proliferation, migration, and invasion. It also downregulated fibronectin 1 (FN1) and caveolin 1 (CAV1), reduced phosphorylation of SRC, focal adhesion kinase (FAK), and FYN, decreased integrin alpha 2b (ITGA2B)+/integrin beta 1 (ITGB1)+ cells, and reduced interleukin‐1 beta (IL‐1β), interleukin‐6 (IL‐6), tumor necrosis factor alpha (TNF‐α), matrix metallopeptidase 3 (MMP3), and matrix metallopeptidase 9 (MMP9). Overall, XuanBi exerted anti‐inflammatory and anti‐synovial‐hyperplasia effects in experimental RA, accompanied by changes in proteins associated with these pathways, supporting the potential involvement of these pathways and warranting further mechanistic and clinical investigation.
SN  - 2048-7177
ER  -